Oncology Partnership Forum 2017

 

 Oncology Partnership Forum 2017 

The Academy of Managed Care Pharmacy (AMCP) held a Partnership Forum “Driving Value and Outcomes in Oncology” on Nov. 14 and 15 outside of Washington, D.C. More than 30 experts from across the country discussed topics such as the importance of greater cost transparency for patients, and the need for new quality and value measures. The November Partnership Forum, AMCP’s second event focusing on value in oncology, builds on results of last year’s forum as well as recent research on gaps in measuring outcomes in oncology care and new cancer medicines. AMCP will use the results of this event to inform future strategic initiatives and advocacy efforts.

The Forum was moderated by Susan Winckler, Chief Risk Management Officer, Leavitt Partners and Former Chief of Staff of the US Food and Drug Administration.

The Forum was held in partnership with Abbvie, Amgen, AstraZeneca, Foundation Medicine, Genentech, Gilead, Eli Lilly and Company, Merck, Sanofi, Takeda Oncology and Xcenda.

Additional Materials: 

▶  Forum Program 

▶ Forum Press Release 

▶ Forum Proceedings scheduled to be published in the second quarter of 2018.  

▶ Forum Webinar scheduled for May 16, 2018.  

If you have any questions, please contact Terry Richardson, AMCP's Director of Product Development, at trichardson@amcp.org or 703-684-2606.